Crescentic Glomerulonephritis (Archived).
Parmar MS, Bashir K.
2023 Feb 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Rapidly Progressive Glomerulonephritis.
Rout P, Naik RH, Leslie SW.
2024 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Crescentic glomerulonephritis in children.
Mayer U, Schmitz J, Bräsen JH, Pape L.
Pediatr Nephrol. 2020 May;35(5):829-842. doi: 10.1007/s00467-019-04436-y. Epub 2020 Feb 12.
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury.
Lodka D, Zschummel M, Bunse M, Rousselle A, Sonnemann J, Kettritz R, Höpken UE, Schreiber A.
Ann Rheum Dis. 2024 Mar 12;83(4):499-507. doi: 10.1136/ard-2023-224875.
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
Moroni G, Ponticelli C.
Autoimmun Rev. 2014 Jul;13(7):723-9. doi: 10.1016/j.autrev.2014.02.007. Epub 2014 Mar 19.
[Crescentic glomerulonephritis].
Ueno M, Arakawa M.
Nihon Rinsho. 1994 Aug;52(8):2082-8.
Crescentic lupus glomerulonephritis.
Yeung CK, Wong KL, Wong WS, Ng MT, Chan KW, Ng WL.
Clin Nephrol. 1984 May;21(5):251-8.
Crescentic glomerulonephritis: data from the Spanish Glomerulonephritis Registry.
Quiroga B, Vega A, Rivera F, López-Gómez JM; Spanish Registry of Glomerulonephritis.
Intern Med J. 2015 May;45(5):557-62. doi: 10.1111/imj.12725.
Outcomes and risk factors in patients with crescentic glomerulonephritis: a multicenter cohort study.
Su X, Song R, Li S, Guo W, Guo X, Qiao X, Wang L.
J Nephrol. 2023 May;36(4):1027-1035. doi: 10.1007/s40620-022-01550-3. Epub 2023 Feb 14.
C3 glomerulonephritis with a severe crescentic phenotype.
Ravindran A, Fervenza FC, Smith RJH, Sethi S.
Pediatr Nephrol. 2017 Sep;32(9):1625-1633. doi: 10.1007/s00467-017-3702-8. Epub 2017 Jun 7.
